(Q46423087)

English

Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma

scientific article published on 19 August 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18712279

Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18712279

author name string

Francesca Valcamonico

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18712279

Vittorio Ferrari

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18712279

Vito Amoroso

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18712279

Giovanni Rangoni

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18712279

Edda Simoncini

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18712279

Patrizia Marpicati

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18712279

Lucia Vassalli

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18712279

Salvatore Grisanti

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18712279

Giovanni Marini

9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18712279

publication date

19 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18712279

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18712279

91

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18712279

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18712279

47-50

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18712279

https://scigraph.springernature.com/pub.10.1007/s11060-008-9676-4

0 references

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18712279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18712279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18712279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal-cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18712279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protein kinase inhibitors in the treatment of renal cell carcinoma: sorafenib

1 reference

https://pubmed.ncbi.nlm.nih.gov/18712279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18712279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sorafenib in advanced clear-cell renal-cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18712279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18712279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18712279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm

1 reference

https://pubmed.ncbi.nlm.nih.gov/18712279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete cerebral response with sunitinib for metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18712279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sunitinib relieves renal cell carcinoma spinal cord compression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18712279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-008-9676-4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18712279

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18712279

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46423087&oldid=2110548710"